Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

July 10, 2006 Approval Letter - Fluzone

Our Submission Tracking Number (STN): BL 103914/5125

July 10, 2006

Sanofi Pasteur, Inc.
Attn: Gary Chikami, M.D.
Discovery Drive
Swiftwater, PA 18370

Dear Dr. Chikami:

We have approved your request to supplement your Biologics License Application for Influenza Virus Vaccine, to include the United States formulation and label revisions for the 2006-2007 influenza season.

We will include the information contained in the above referenced supplement in your Biologics License Application file.

Please submit all final printed labeling and implementation information on FDA Form 356h. Please provide an PDF-format electronic copy as well.

Sincerely yours

Jerry P. Weir, Ph.D.
Division of Viral Products
Office of Vaccines Research and Review
Center for Biologics Evaluation and Research

Attachment: Final Draft labeling of Package insert, Carton, and Container

Return to product page

Page Last Updated: 03/30/2009
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English